Abstract
The transcription factors of the nuclear factor of activated T cell (NFAT) family play a crucial role in multiple aspects of T cell function. It has recently been reported that NFATs play an important role in the suppressive function of CD4+CD25+Foxp3+ regulatory T (Treg) cells. In this study, we have investigated the role of NFATs in the thymic development of Treg cells in mice. We show that NFAT factors are dispensable for the development of Foxp3+ Treg cells in the thymus but are critical for the maintenance of both the phenotype and survival of Treg cells in the thymus as well as in peripheral lymphoid organs. Specifically, the homeostasis of CD4+CD25+Foxp3+ but not the CD4+CD25−Foxp3+ fraction is severely perturbed when NFAT signaling is blocked, leading to a strongly reduced Treg population. We underscored this intriguing effect of NFAT on CD4+CD25+Foxp3+ Treg cells to the disruption of survival signals provided by interleukin 2 (IL-2). Accordingly, blocking Treg cell death by abolishing the activity of pro-apoptotic Bcl-2 family member Bim, compensated for the survival defects induced due to a lack of NFAT-IL-2-IL-2R signaling. Inhibition of NFAT activity led to a strong reduction in the number of Foxp3+ Treg cells; however, it did not influence the level of Foxp3 expression on an individual cell basis. In addition, we show a differential effect of IL-2 and IL-7 signaling on Foxp3+ Treg versus CD4+CD25− T cell development, again underlining the dispensability of NFAT signaling in the development, but not in the maintenance of Foxp3+ Treg cells.
Original language | English |
---|---|
Article number | 1397 |
Journal | Cells |
Volume | 11 |
Issue number | 9 |
Early online date | 20 Apr 2022 |
DOIs | |
Publication status | Published - 1 May 2022 |
Externally published | Yes |
Bibliographical note
Funding Information:This work was supported by an ?EMBO Short Term Fellowship? (ATF No: 93-06), a ?PostDoc Plus Funding? grant (Graduate School of Life Sciences; GSLS, University of Wuerzburg) and a fellowship from the Vandervell Foundation, UK to A.K.P.We thank T. Schueler, Institute of Immunology, Charit?, Berlin for the Il7r-/-mice, V. Ellenrieder (University of Goettingen) for the Nfatc1?Afl/fl mice, D. J. Murphy (University of Glasgow, U.K.) for Bim-/-, and T. Sparwasser (Institute of Infection Immunology, TWINCORE, Center for Experimental and Clinical Infection Research, Hannover) for the DEREG mice, and C. Linden (University of Wuerzburg) for excellent FACS sorting. We thank E. Serfling, Institute of Pathology, University of Wuerzburg, for his guidance and in facilitating this study (Animal Experimentation Licence: approved by the Regierung von Unterfranken, Wuerzburg, Permit Number 55.2-2531.01-53/10B to E.S.).
Funding Information:
Funding: This work was supported by an ‘EMBO Short Term Fellowship’ (ATF No: 93-06), a ‘PostDoc Plus Funding’ grant (Graduate School of Life Sciences; GSLS, University of Wuerzburg) and a fellowship from the Vandervell Foundation, UK to A.K.P.
Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.
Keywords
- cyclosporine A
- NFAT
- T and Foxp3
- thymocytes
ASJC Scopus subject areas
- General Medicine